HK Stock Market Move | MARKETINGFORCE (02556) rose more than 8% in mid-day trading, with a large growth potential in the GEO market. The company has built a complete AI-native marketing closed loop.
Mai Fu Shi (02556) rose by over 8% intraday, and as of the time of writing, it had risen by 5.27% to 53.95 Hong Kong dollars, with a turnover of 3.65 billion Hong Kong dollars.
MARKETINGFORCE (02556) rises over 8% during the day, up 5.27% by press time to HKD 53.95, with a total transaction volume of HKD 3.65 billion.
On the news front, Musk recently stated that he will officially open source the latest content recommendation algorithm for the X platform within a week. This move is widely interpreted by the market as "Musk also entering the GEO sector". Northeast believes that in the AI era, GEO has become a must for enterprise marketing, with great potential for market growth. According to Semrush's predictions, AI searches will account for 52% in January 2028, surpassing traditional searches and continuing to rise; according to the "2025 China GEO Industry Development Report", the global GEO market is expected to reach $11.2 billion in 2025, and is projected to reach $100.7 billion in 2030, with the Chinese GEO market expected to achieve $2.9 billion in 2025 and $24 billion in 2030.
As a leading global AI application platform, MARKETINGFORCE has served over 210,000 enterprises. Currently, MARKETINGFORCE's GEO has been deeply implemented in various industries such as retail consumption, B2B manufacturing, automotive, home furnishings, health, culture and tourism, and international trade expansion. In addition, MARKETINGFORCE recently announced the upgrade of the GEO intelligent assistant. Strengthening the Generative Engine Optimization (GEO) technology, constructing a full-link AI-native marketing loop, helping enterprises seize the high ground of AI search traffic in the AGI era, consolidating brand AI cognitive assets, and strengthening the full-link competitive advantage in consumer decision-making.
Related Articles
.png)
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.

HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.
HK Stock Market Move | SINO BIOPHARM(01177) rises more than 4%, management is optimistic about the prospects of VIIa being included in insurance coverage. The drug is developed by its subsidiary, Zhongda Tianqing.
.png)
HK Stock Market Move | IMMUNEONCO-B(01541) rose by more than 10% in early trading. IMM01 has been approved for clinical trials for the treatment of atherosclerosis.

Furui: Lower target price of LAOPU GOLD (06181) to 981 Hong Kong dollars. High gold prices suppress gross profit.

RECOMMEND

Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026

Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026

“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026


